Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
Gorden Muduma,1 Jane Shaw,2 Warren M Hart,3 Abayomi Odeyemi,3 Isaac Odeyemi21Astellas Pharma Europe Limited, Chertsey, UK; 2Astellas Pharma Limited, Chertsey, UK; 3EcoStat Consulting UK Limited, London, UKBackground: End-stage renal disease is the irreversible final stage of chronic kidney disease a...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-11-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/cost-utility-analysis-of-immunosuppressive-regimens-in-adult-renal-tra-peer-reviewed-article-PPA |